Last reviewed · How we verify

Concerta

Lei Lei, MD · FDA-approved active Small molecule Quality 16/100

Concerta is a Small molecule drug developed by Lei Lei, MD. It is currently FDA-approved for Attention deficit hyperactivity disorder, Narcolepsy. Also known as: Methylphenidate Hydrochloride Extended-Release Tablets, methylphenidate hydrochloride, Methylphenidate, Methylphenidate HCL.

Concerta, marketed by Lei Lei, MD, is an established treatment for attention deficit hyperactivity disorder (ADHD). The drug's key strength lies in its well-established market presence, supported by a key composition patent that remains in effect until 2028. The primary risk to Concerta is the eventual patent expiry in 2028, which could lead to increased competition from generic alternatives.

At a glance

Generic nameConcerta
Also known asMethylphenidate Hydrochloride Extended-Release Tablets, methylphenidate hydrochloride, Methylphenidate, Methylphenidate HCL, Methylphenidate hydrochloride (HCl)
SponsorLei Lei, MD
TargetAlpha-2A adrenergic receptor, Alpha-2B adrenergic receptor, Alpha-2C adrenergic receptor
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

Common side effects

Serious adverse events

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Concerta

What is Concerta?

Concerta is a Small molecule drug developed by Lei Lei, MD, indicated for Attention deficit hyperactivity disorder, Narcolepsy.

What is Concerta used for?

Concerta is indicated for Attention deficit hyperactivity disorder, Narcolepsy.

Who makes Concerta?

Concerta is developed and marketed by Lei Lei, MD (see full Lei Lei, MD pipeline at /company/lei-lei-md).

Is Concerta also known as anything else?

Concerta is also known as Methylphenidate Hydrochloride Extended-Release Tablets, methylphenidate hydrochloride, Methylphenidate, Methylphenidate HCL, Methylphenidate hydrochloride (HCl).

What development phase is Concerta in?

Concerta is FDA-approved (marketed).

What are the side effects of Concerta?

Common side effects of Concerta include Anxiety, Irritability, Increased blood pressure, Nervousness, Insomnia, Decreased appetite. Serious adverse events: Priapism, Peripheral Vasculopathy, including Raynaud's Phenomenon, Long-Term Suppression of Growth in Pediatric Patients, Acute Angle Closure Glaucoma.

What does Concerta target?

Concerta targets Alpha-2A adrenergic receptor, Alpha-2B adrenergic receptor, Alpha-2C adrenergic receptor.

Related